Concepedia

Michelle Geller

MG

Statistics

Publications

6

Citations

465

H-Index

6

Active since

1983

Affiliations

Amgen (United States)(Current)

Amgen (United Kingdom)

Leiden University Medical Center

Michelle Geller is an author at Amgen (United States) specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

Publications per year

1983–2016

6

Publications

6

The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension

Henry G. Bone, Roland Chapurlat, Maria Luisa Brandi et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 249 citations · Full text

Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial

Michael R. McClung, E. Michael Lewiecki, Michelle Geller et al. · Osteoporosis International · 2012 · 113 citations · Full text

Inhibitors of peripheral-type benzodiazepine receptors present in human urine and plasma ultrafiltrates

Kevin Beaumont, Alfred K. Cheung, Michelle Geller et al. · Life Sciences · 1983 · 35 citations

, , +7

Evolocumab lowers LDL-C safely and effectively when self-administered in the at-home setting

Ricardo Dent, Raju Joshi, C. Stephen Djedjos et al. · SpringerPlus · 2016 · 27 citations · Full text

Evaluation of Evolocumab (AMG 145), a Fully Human Anti‐PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic Impairment

John P. Gibbs, J. Greg Slatter, Ogo Egbuna et al. · The Journal of Clinical Pharmacology · 2016 · 24 citations · Full text

, , +23

1–5 of 6